TW200745097A - 4-Phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors - Google Patents

4-Phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors

Info

Publication number
TW200745097A
TW200745097A TW096106341A TW96106341A TW200745097A TW 200745097 A TW200745097 A TW 200745097A TW 096106341 A TW096106341 A TW 096106341A TW 96106341 A TW96106341 A TW 96106341A TW 200745097 A TW200745097 A TW 200745097A
Authority
TW
Taiwan
Prior art keywords
thiazole
phenyl
acid amides
carboxylic acid
carboxylic acids
Prior art date
Application number
TW096106341A
Other languages
English (en)
Inventor
John Frederick Boylan
jian-ping Cai
Nader Fotouhi
Paul Gillespie
Robert Alan Goodnow Jr
Kang Le
Christophe Michoud
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of TW200745097A publication Critical patent/TW200745097A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
TW096106341A 2006-02-27 2007-02-26 4-Phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors TW200745097A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77696406P 2006-02-27 2006-02-27

Publications (1)

Publication Number Publication Date
TW200745097A true TW200745097A (en) 2007-12-16

Family

ID=38051896

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096106341A TW200745097A (en) 2006-02-27 2007-02-26 4-Phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors

Country Status (19)

Country Link
US (1) US7504513B2 (zh)
EP (1) EP1991543A1 (zh)
JP (1) JP2009528284A (zh)
KR (1) KR101060539B1 (zh)
CN (1) CN101415704A (zh)
AR (1) AR059621A1 (zh)
AU (1) AU2007217575A1 (zh)
BR (1) BRPI0710473A2 (zh)
CA (1) CA2642921A1 (zh)
CR (1) CR10206A (zh)
EC (1) ECSP088700A (zh)
IL (1) IL193481A0 (zh)
MA (1) MA30260B1 (zh)
MX (1) MX2008010884A (zh)
NO (1) NO20083708L (zh)
RU (1) RU2008138163A (zh)
TW (1) TW200745097A (zh)
WO (1) WO2007096315A1 (zh)
ZA (1) ZA200807074B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5246158B2 (ja) * 2007-06-08 2013-07-24 日本電気株式会社 半導体集積回路及びフィルタ制御方法
US9029411B2 (en) 2008-01-25 2015-05-12 Millennium Pharmaceuticals, Inc. Thiophenes and uses thereof
WO2009128805A1 (en) * 2008-04-17 2009-10-22 The Johns Hopkins University On01910. na enhances chemotherapeutic agent activity in drug-resistant tumors
ES2388570T3 (es) * 2008-09-10 2012-10-16 Datalase Ltd Medio de almacenamiento de datos
WO2010077295A1 (en) * 2008-12-09 2010-07-08 King Faisal Specialist Hospital & Research Centre Substituted tricyclic heterocycles and uses to treat tumors and proliferative disorders
JP2012512223A (ja) * 2008-12-18 2012-05-31 エフ.ホフマン−ラ ロシュ アーゲー チアゾリル−ベンズイミダゾール類
US8796314B2 (en) 2009-01-30 2014-08-05 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
CN102395585A (zh) * 2009-01-30 2012-03-28 米伦纽姆医药公司 杂芳基化合物和其作为pi3k抑制剂的用途
US9090601B2 (en) * 2009-01-30 2015-07-28 Millennium Pharmaceuticals, Inc. Thiazole derivatives
JP2013533318A (ja) 2010-08-11 2013-08-22 ミレニアム ファーマシューティカルズ, インコーポレイテッド ヘテロアリールおよびその使用
PE20131304A1 (es) 2010-08-11 2013-11-14 Millennium Pharm Inc Heteroarilos y sus usos
US9062038B2 (en) 2010-08-11 2015-06-23 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
UY33671A (es) 2010-10-13 2012-04-30 Millenium Pharmaceuticals Inc Heteroarilos y sus usos

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322429A (en) 1980-09-16 1982-03-30 Eli Lilly And Company Isoxazolylbenzamides as insecticides
US4818270A (en) 1986-08-28 1989-04-04 Monsanto Company 2-(Heteroamino)-4,5-substituted-oxazole/thiazole compounds as herbicide antidotes, compositions and use
US6194447B1 (en) 1998-07-02 2001-02-27 Neurosearch A/S Bis (benzimidazole) derivatives serving as potassium blocking agents
EA006381B1 (ru) 2000-08-10 2005-12-29 Фармация Италия С.П.А. Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции
GB0102687D0 (en) 2001-02-02 2001-03-21 Pharmacia & Upjohn Spa Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
AU2003206946A1 (en) 2002-02-22 2003-09-09 Klaus Strebhardt Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent
JP2003321460A (ja) * 2002-02-28 2003-11-11 Takeda Chem Ind Ltd アゾール化合物
WO2003072554A1 (en) * 2002-02-28 2003-09-04 Takeda Chemical Industries, Ltd. Azole compounds
IL163607A0 (en) 2002-02-28 2005-12-18 Univ Temple Amino-substituted 2,6-dialkoxystyryl 4-substitutedbenzylsulfones for treating proliferative disorders
US20060079503A1 (en) 2002-05-03 2006-04-13 Schering Aktiengesellschaft Thiazolidinones and the use therof as polo-like kinase inhibitors
US6906186B1 (en) 2002-07-30 2005-06-14 Isis Pharmaceuticals, Inc. Antisense modulation of polo-like kinase expression
WO2004014899A1 (en) * 2002-08-08 2004-02-19 Smithkline Beecham Corporation Thiophene compounds
AU2003284399A1 (en) 2002-11-14 2004-06-03 Kyowa Hakko Kogyo Co., Ltd. Plk inhibitors
WO2004046317A2 (en) 2002-11-14 2004-06-03 Massachusetts Institue Of Technology Products and processes for modulating peptide-peptide binding domain interactions
JP3837670B2 (ja) 2002-12-12 2006-10-25 富士通株式会社 データ中継装置、連想メモリデバイス、および連想メモリデバイス利用情報検索方法
GB0302220D0 (en) 2003-01-30 2003-03-05 Cyclacel Ltd Use
ES2325440T3 (es) 2003-02-20 2009-09-04 Smithkline Beecham Corporation Compuestos de pirimidina.
ATE432936T1 (de) 2003-04-01 2009-06-15 Smithkline Beecham Corp Imidazotriazin verbindungen zur behandlung von krebserkrankungen
JP2007516168A (ja) 2003-06-24 2007-06-21 ファイザー・プロダクツ・インク 1−[2−(ベンゾイミダゾル−1−イル)キノリン−8−イル]−ピペリジン−4−イルアミン誘導体の製造方法
WO2005019193A2 (en) 2003-08-20 2005-03-03 Smithkline Beecham Corporation Phenylurea derivatives useful in the treatment of conditions mediated by polo-like kinases (plk)
CA2542880A1 (en) 2003-10-21 2005-05-12 Cyclacel Limited Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy
DE10351744A1 (de) 2003-10-31 2005-06-16 Schering Ag Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel
WO2005075470A1 (en) 2004-01-28 2005-08-18 Smithkline Beecham Corporation Thiazole compounds

Also Published As

Publication number Publication date
ECSP088700A (es) 2008-09-29
KR101060539B1 (ko) 2011-08-30
WO2007096315A1 (en) 2007-08-30
AR059621A1 (es) 2008-04-16
IL193481A0 (en) 2009-05-04
CR10206A (es) 2008-09-22
CN101415704A (zh) 2009-04-22
NO20083708L (no) 2008-09-23
RU2008138163A (ru) 2010-04-10
BRPI0710473A2 (pt) 2011-08-16
KR20080090550A (ko) 2008-10-08
JP2009528284A (ja) 2009-08-06
CA2642921A1 (en) 2007-08-30
MA30260B1 (fr) 2009-03-02
MX2008010884A (es) 2008-09-03
US7504513B2 (en) 2009-03-17
US20070203210A1 (en) 2007-08-30
ZA200807074B (en) 2009-10-28
EP1991543A1 (en) 2008-11-19
AU2007217575A1 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
TW200745097A (en) 4-Phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors
TW200728307A (en) Novel spirochromanone derivatives
RS52823B (en) NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
UA93393C2 (uk) 1,3-діоксанкарбонові кислоти
SG151286A1 (en) 5-substituted-2-phenylamino-benzamide as mek inhibitor
TN2011000400A1 (en) Inhibitors of beta-secretase
MY143568A (en) 11b-hsd1 inhibitors for the treatment of diabetes
MX2009006756A (es) Derivados de 1-amino-metil-l-fenil-ciclohexano como inhibidores de dpp-iv.
EA201270046A1 (ru) Новые производные фенилимидазола в качестве ингибиторов фермента pde10a
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
WO2009066152A3 (en) Haloallylamine inhibitors of ssao/vap-1 and uses therefor
RS53617B1 (en) NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
HK1119699A1 (en) Pyridopyrimidinone inhibitors of pi3kalpha
PT1940839E (pt) Inibidores de piridopirimidinona pi3k alfa
MXPA05008172A (es) Derivados de malonamida como inhibidores gamma-secretasa.
PT2323972E (pt) Compostos de tetraciclina substituídos com c7-flúor
MY151295A (en) Pyrimidyl indoline compound
MX2009003739A (es) Derivados de hidrobenzamida como inhibidores de hsp90.
MX2009005357A (es) Derivados de hidantoina usados como inhibidores de metaloproteinasas de matriz.
EP2639229A3 (en) Thiazole Derivative and use thereof as VAP-1 Inhibitor
MX2010005824A (es) Derivados de aminotiazol.
MX2012004311A (es) Derivados de ciclohexano spiro condensados como inhibidores de lipasa sensible a hormonas (hsl) utiles en el tratamiento de diabetes.
IN2012DN02502A (zh)
IL195016A0 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
ATE466007T1 (de) 5-substituierte indol-2-carbonsäureamidderivate